Given that there may well be no significant advances in drug development before 2025, prevention of dementia/AD through the management of vascular and lifestyle-related risk factors may be a more realistic goal than treatment. Level of education and cognitive reserve assessment in neuropsychological testing deserve ...
-
March 3, 2015 (v1)Journal articleUploaded on: December 4, 2022
-
2007 (v1)Report
La maladie d'Alzheimer est une véritable pathologieet non un simple effet du vieillissement même si ellese révèle, le plus souvent, aux âges avancés de la vie.La détérioration progressive intellectuelle et physiqueassociée à cette maladie est douloureusement ressentiepar les proches qui accompagnent au quotidienle patient. Les différentes...
Uploaded on: February 28, 2023 -
September 13, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
March 24, 2014 (v1)Journal article
Alzheimer's disease and other related disorders (ADRD) represent a major challenge for health care systems within the aging population. It is therefore important to develop better instruments to assess the disease severity and progression, as well as to improve its treatment, stimulation, and rehabilitation. This is the underlying idea for the...
Uploaded on: March 25, 2023